Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma
Clinical trial NCT00556127 · COMPLETED
Trial details
- NCT number
- NCT00556127
- Sponsor
- Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.